SCHEMBL21525231

SCHEMBL21525231

Cc1cscc1-c1ccnc(NC(C)c2cc3cc(Cl)ccc3[nH]c2=O)n1

nearest known ligand 0.75

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 20/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17601600 1.00 IDH1 (0.75) IDH1
SCHEMBL17601169 0.89 IDH1 (0.62) IDH1
SCHEMBL17601287 0.87 IDH1 (0.59) IDH1
SCHEMBL17601392 0.85 IDH1 (1.00) IDH1
SCHEMBL21525325 0.85 IDH1 (1.00) IDH1
SCHEMBL17601144 0.85 IDH1 (0.61) IDH1
SCHEMBL21525329 0.85 IDH1 (0.57) IDH1
SCHEMBL17601107 0.85 IDH1 (0.57) IDH1
SCHEMBL17601654 0.85 IDH1 (0.54) IDH1
SCHEMBL17601065 0.85 IDH1 (0.55) IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3194383-B1 QUINOLINONE PYRIMIDINES COMPOSITIONS AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS FORMA THERAPEUTICS INC (US) 2019-11-06 — — EP claimed
Send feedback